All Blogs / Health / Diseases & Conditions / Multiple Sclerosis / Popular

Trial to Evaluate H.P. Acthar Gel Is Enrolling Patients with Relapsing-remitting MS

Mallinckrodt Pharmaceuticals is seeking 66 participants for a clinical trial to determine the safety and effectiveness of its injected therapy H.P. Acthar Gel as a treatment for acute relapses in people with relapsing-remitting multiple sclerosis (RRMS). Show More Summary

How a Lumbar Puncture Can Help Diagnose MS

According to the MS Trust, a lumbar puncture (also known as a spinal tap) is a test that can be used to help diagnose multiple sclerosis (MS). During the procedure, some of the cerebrospinal fluid is removed and analyzed. A lumbar puncture takes about half an hour and is done under a local anaesthetic. Show More Summary

The Stigma Surrounding Depression

Lots of columns and articles look at issues surrounding the topics of depression and mental health-related disorders. I have referenced them in various columns. What saddens me is the stigma surrounding depression that prevails in our society. Show More Summary

Most relapsing-remitting multiple sclerosis patients dropout ot switch from DMF treatment, a study shows.

  A study shows that most relapsing-remitting multiple sclerosis (RRMS) patients who initiate dimethyl fumarate (DMF) treatment either dropout or switch to another therapy within a two-year period. The team believes that the great expectations hold for DMF therapy (Tecfidera) promoted its rapid acceptance among patients and healthcare professionals. Show More Summary

A Tough Year to Fight the Flu

I’m fighting a cold. I’m coughing and I’m congested. I’m hoping it’s not the flu. This is not a year to get the flu. The type of flu circulating in most of North America right now is the H3N2 variety. And, in the words of Helen Branswell...Show More Summary

Myelin Loss Can Be Assessed With Innovative Imaging Approach, Study Suggests

A novel imaging approach enables assessment of key nervous system deterioration in multiple sclerosis (MS), a new study in mice suggests. The research, “Development of a PET radioligand for potassium channels to image CNS demyelination,” was published in the journal Scientific Reports. Show More Summary

Long-term Rituxan Treatment Is Effective and Safe in MS, Study Shows

The approved lymphoma therapy Rituxan (rituximab) has shown promise as a treatment for  multiple sclerosis. A new study indicates the Genentech treatment is effective and safe against neurological diseases like MS for up to seven years. Show More Summary

Grieving the Loss of a Loved One

One year ago, I wrote “Grief, Self-preservation and Multiple Sclerosis.” My writing dealt with the fact that, years ago, I was living submersed in sorrow after the passing of my mother and father. I was overshadowed by grieving and I truly believe that grief propelled my multiple sclerosis (MS) into a rapid downward progression. Show More Summary

MS News that Caught My Eye Last Week: Rituxan, Medical Marijuana for Canadians, Extavia, Atira Trial

Newly Diagnosed MS Patients Stay Longer on Rituxan Than Other Therapies, Study Finds This is a study that identifies which disease-modifying drugs new MS patients stuck with and which they gave up. And, why they made those choices. But the study is small and was limited to patients in two areas of Sweden. Show More Summary

European Commission Approves Ocrevus to Treat RRMS, PPMS Throughout EU

The European Commission has approved Roche’s Ocrevus (ocrelizumab) for both relapsing-remitting multiple sclerosis (RRMS) and primary-progressive multiple sclerosis (PPMS) across the 28-member European Union. The commission’s move —  nearly 10 months after the U.S. Show More Summary

Probiotics Increase Punch of Treatments That Decrease Inflammation in MS, Study Shows

Probiotics increased the punch of treatments that decrease the inflammation associated with multiple sclerosis, a study found. Using the supplements to add helpful bacteria to the gut may be a way to improve patients’  outcomes, researchers added. Show More Summary

5 Benefits of Cannabis Tea for Chronic Illnesses

Medical marijuana is gaining popularity as a complementary medicine to help with many symptoms associated with chronic illnesses. While many people are curious about how marijuana (or cannabis) may help improve their symptoms, they are also reluctant to smoke the substance. Show More Summary

A Quiet Week

I could be in a fancy restaurant in central London rather than sitting at home writing this. Don’t feel sorry for me, I chose to stay in. The Christmas month of December is very hard. Extreme partying is allied with extreme levels of work. Show More Summary

Worrying About the Dye Used in My MRIs

The Food and Drug Administration (FDA) issued a safety alert about gadolinium, the dye that’s injected when our doctors order a brain MRI “with and without” contrast. The dye provides the contrast that “lights up” areas of MS inflammation in the brain. Show More Summary

Researcher Wins National MS Society Grant to Study Patients’ Emotional Processing Challenges

A $44,000 National Multiple Sclerosis Society grant will allow a researcher at the Kessler Foundation to advance her work on multiple sclerosis patients’ emotional processing challenges. Dr. Helen Genova, Kessler’s assistant director...Show More Summary

Atara to Extend Phase 1 Trial of Potential Immunotherapy for All MS Forms to US Patients

Atara Biotherapeutics has received a green light to enroll U.S. patients into a Phase 1 trial of ATA188 for progressive or relapsing-remitting multiple sclerosis (MS). The study was initially launched in Australia, but with the U.S.Show More Summary

The MS Alphabet: Prednisone, Ptosis, PwMS, and Other ‘P’ Words (Part 2 of 7)

Editor’s note: Tamara Sellman continues her occasional series on the MS alphabet with the second column in a series of seven referencing terms starting with the letter “P.” Symptoms of MS Ptosis Commonly referred to as “droopy eyelid,”...Show More Summary

Employment and MS

For many of us, our careers define a large part of our identities. Conversely, an MS diagnosis can put a wrench in how we view and think of ourselves in the workforce. As an unpredictable disease, MS can have varying effects on a person’s ability to work—whether an individual can continue to do the same kind of work, or even work at all. Show More Summary

Moving into the New Year with MS: Resolute to Live Each Day

I have always loved the start of New Year’s; tabula rasa, clean slate. Much like a snake shedding its skin, we leave behind the old and embrace the new, or at least accept such. While Dec. 31 is ripe with well-intentioned resolutions, I avoid promising myself anything simply because the calendar year is over. Show More Summary

Copyright © 2015 Regator, LLC